Josh Gottheimer (D-NJ)

Lung Cancer Medicare Access to Precise Testing Act

H.R. 6321 · House bill Health

A Democratic bill with 1 Republican cosponsor · See all 3 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "Lung Cancer Medicare Access to Precise Testing Act," seeks to change the Social Security Act. It would require the Medicare program to cover lung cancer biomarker testing. This type of testing involves analyzing an individual's tissue, blood, or bodily fluids to identify specific biomarkers like genes or proteins. The coverage would apply to individuals diagnosed with lung cancer for tests furnished on or after January 1, 2027. Additionally, the bill mandates that Medicare pay 100 percent of the reasonable charges for this specific testing.

Yes· 3 of 5

  • Scored +8

    Would people over 65 be better off under this?

    The bill provides full Medicare coverage for lung cancer biomarker testing, which benefits many seniors undergoing cancer treatment.

  • Scored +8

    Would retired people be better off under this?

    The bill ensures that retirees on Medicare have access to full coverage for critical lung cancer biomarker testing.

  • Scored +8

    Does this make health care easier to get in general?

    The bill mandates Medicare coverage for essential lung cancer biomarker testing, facilitating easier access to precise diagnostics.

The opposite

No question was scored the opposite.